SEMA7A and ductal breast carcinoma in situ: To expand our analysis to SEMA7A protein in patient tissues, we examined SEMA7A expression in tissue microarrays (TMA) from patient biopsies that contain DCIS only (TMA1) or IDC with histologically distinct DCIS remnants (TMA2) and compared to matched NAT (Fig. 1A–B).